Pathogenesis

NIH-funded T32 Research Training Funds

Accepting nominations for **RESEARCH TRAINING FUNDS AVAILABLE FOR JUNE/JULY 2022**

December 8, 2021

NIH-funded T32 Research Training Funds to Massachusetts General Hospital, Brigham and Women’s Hospital, Harvard Medical School, Harvard T.H. Chan School of Public Health, Beth Israel Deaconess Medical Center, and Boston Children’s Hospital with funding slots available beginning June 1 and July 1, 2022.

...

Read more about Accepting nominations for **RESEARCH TRAINING FUNDS AVAILABLE FOR JUNE/JULY 2022**
HU CFAR Grand Rounds : Cutting Edge Solutions in HIV Research

HU CFAR Grand Rounds video recordings

June 8, 2021

The Harvard University Center for AIDS Research virtual Grand Rounds series represents an opportunity for Harvard-affiliated HIV researchers and their collaborators to learn about and share high impact, cutting-edge research to the HU CFAR community. If you’re interested in presenting at a future webinar, suggest a topic, or learn more about it, please contact Mark Ingaciola at ...

Read more about HU CFAR Grand Rounds video recordings

PAR-21-070: Detection of HIV for Self-Testing (R61/R33 Clinical Trial Not Allowed)

November 20, 2020

AIDS Application Due Dates:  March 17, 2021; March 17, 2022; March 17, 2023

See full details: Detection of HIV for Self-Testing (R61/R33 Clinical Trial Not Allowed)

Purpose: to support innovative, collaborative, interdisciplinary early-stage research to inform the development of innovative rapid, sensitive, simple, and cost-effective...

Read more about PAR-21-070: Detection of HIV for Self-Testing (R61/R33 Clinical Trial Not Allowed)

Preventative HIV vaccine candidate triggers desired immune responses in humans and monkeys, and protects monkeys from infection

July 10, 2018

Promising findings lead to initiation of a clinical efficacy trial in southern Africa

BOSTON - More than three decades after the identification of the human immunodeficiency virus (HIV), scientists are still working to develop a preventative vaccine that could finally put an end to the epidemic for which there are nearly two million new infections each year. 

...

Read more about Preventative HIV vaccine candidate triggers desired immune responses in humans and monkeys, and protects monkeys from infection
GW University School of Medicine

Apply now for the position of Chair, Department of Microbiology, Immunology, and Tropical Medicine: Washington, DC, United States

June 4, 2018

The George Washington University School of Medicine and Health Sciences (SMHS) invites applications and nominations for the position of chair of the Department of Microbiology, Immunology, & Tropical Medicine (MITM).

Apply here: https://www.gwu.jobs/postings/51785

Read more about Apply now for the position of Chair, Department of Microbiology, Immunology, and Tropical Medicine: Washington, DC, United States
Forsyth

Postdoctoral Research Fellow Position Available at the Forsyth Institute, Cambridge, MA

August 10, 2017

A position for a postdoctoral research fellow is immediately available at the Forsyth Institute in Cambridge, Massachusetts             

We are very excited to embark on a NIH-sponsored project to develop a novel oral vaccine against HIV/AIDS. A postdoctoral fellow with a strong background in Immunology is sought for the careful planning and implementation of research projects involving assessments of mucosal/cellular immune responses to our novel HIV vaccine.

Please send submissions via...

Read more about Postdoctoral Research Fellow Position Available at the Forsyth Institute, Cambridge, MA
Scott Dryden-Peterson

Botswana’s cautionary tale of the co-epidemic of HIV and cervical cancer

October 13, 2016

HIV infection increases mortality in African women with cervical cancer

“Botswana was the first country in Africa to provide comprehensive HIV treatment to its citizens and has one of the most effective antiretroviral treatment programs globally,” Scott Dryden-Peterson, MD, instructor of medicine at Harvard Medical School and associate physician at Brigham and Women’s Hospital, told HemOnc Today. “As such, trends in Botswana are indicative of what will happen in other heavily HIV affected countries that also now have good access...

Read more about Botswana’s cautionary tale of the co-epidemic of HIV and cervical cancer

Pages